Announcements
On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Edition  2017: Volume 22/ Issue 25 Article 1
Back to Table of Contents
Download (pdf)
Next

Eurosurveillance, Volume 22, Issue 25, 22 June 2017
Editorial
Eurosurveillance editorial team: Third Director of the European Centre for Disease Prevention and Control takes office

+ Author affiliations


Citation style for this article: Eurosurveillance editorial team. Third Director of the European Centre for Disease Prevention and Control takes office. Euro Surveill. 2017;22(25):pii=30560. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.25.30560

Received:21 June 2017; Accepted:22 June 2017

On Friday 16 June 2017, Dr Andrea Ammon took up office as the third Director of the European Centre for Disease Prevention and Control (ECDC) following her election by the Centre’s management board earlier the same year. The appointment follows a two-year tenure as acting director during which Dr Ammon steered the ECDC steadily and calmly through a challenging period when besides the Centre’s day-to-day work, expertise and resources were requested for the European preparedness and response to global threats such as the Ebola and Zika virus disease outbreaks in Africa and the Americas [1,2].

Dr Ammon joined the newly established ECDC already in May 2005, as one of its first employees and Head of the Surveillance Unit [3]. While still setting up the unit, she was instrumental in drafting and implementing a long-term surveillance strategy for the European Union (EU). As part of this, she and her enthusiastic team evaluated the existing 17 European Dedicated Surveillance Networks (DSN) which included well-established and widely known networks such as EURO TB and EURO HIV, and gradually transferred them into the ECDC [4]. In parallel, her unit developed The European Surveillance System (TESSy), revised the EU case definitions and produced for the first time an Annual Epidemiological Report on infectious diseases in the EU.

From April 2011 to April 2015, Andrea Ammon was Deputy to the Director and ECDC’s Head of Unit for Resource Management and Coordination. She was a member of the scientific committee for the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) and in 2014 and 2015, she headed the committee.

A medical doctor by training, Dr Ammon discovered her passion for public health early in her career and she has extensive experience in working in public health authorities at differing levels. Starting at the local and then regional level in the German federal state of Bavaria, she moved to the national public health institute, the Robert Koch Institute (RKI) in 1996, where she was among the first national Field Epidemiology Programme trainees and simultaneously a member of the first cohort of the European Programme for Intervention Epidemiology Training (EPIET). At RKI, she became the Head of Department for Infectious Disease Epidemiology and State Epidemiologist for Germany from late 2002 to 2005. Besides coordinating the national outbreak response team for current and emerging infections, she directed the national field epidemiology training programme and coordinated emergency planning for influenza and epidemiological research programmes in infectious diseases. Furthermore, she provided scientific advice for government ministries, Members of Parliament and the public. In 2003, she coordinated the German response to Europe’s first imported case of severe acute respiratory syndrome (SARS). During her time at RKI, Dr Ammon also became a nationally and internationally respected expert in the field of food- and waterborne diseases. Her PhD was on the synergy between epidemiology and microbiology in the prevention and control of food-borne diseases.

Dr Ammon’s professional and leadership skills are complemented by other strong characteristics such as a mind open to suggestions, a capacity for motivating staff and an acute sense of fairness.

The Eurosurveillance journal and its editors benefited from Dr Ammon’s strategic vision and sense for quality between 2007 and 2015, when she was an associate editor and a strong supporter of the journal. She resigned from this position when taking up her post as ECDC Director to mark the editorial independence of the journal from its publisher and its Director.



References

  1. Briand S, Bertherat E, Cox P, Formenty P, Kieny MP, Myhre JK,  et al.  The international Ebola emergency. N Engl J Med. 2014;371(13):1180-3. . Available from: DOI: 10.1056/NEJMp1409858 PMID: 25140855

  2. World Health Organization (WHO). WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barré syndrome; 1 Feb 2016. [Accessed 5 Feb 2016]. Available from: http://www.who.int/mediacentre/news/statements/2016/emergency-committee-zika-microcephaly/en/

  3. Ekdahl K. Senior appointments and new facilities announced as the ECDC is inaugurated.Euro Surveill. 2005;10(6):E050602.5. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2718PMID: 16783094

  4. Amato-Gauci A, Ammon A. The surveillance of communicable diseases in the European Union--a long-term strategy (2008-2013).Euro Surveill. 2008;13(26):18912. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18912PMID: 18761915



Back to Table of Contents
Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.